Cutler Group’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Hold	0	–	–	–	2502
2022 Q2	–	Sell	-1,550	Closed	-$28K	–	2511
2022 Q1	$28K	Buy	+1,550	New	+$28K	﹤0.01%	1250
2021 Q4	–	Hold	0	–	–	–	2677
2021 Q3	–	Hold	0	–	–	–	2786